HEADER VIRAL PROTEIN 20-DEC-21 7WCU TITLE LOCAL CRYOEM STRUCTURE OF THE SARS-COV-2 S6P(B.1.617.2) IN COMPLEX TITLE 2 WITH SWC11 FAB COMPND MOL_ID: 1; COMPND 2 MOLECULE: SWC11H; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: SWC11L; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: SURFACE GLYCOPROTEIN; COMPND 11 CHAIN: R; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 11 MOL_ID: 3; SOURCE 12 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 13 2; SOURCE 14 ORGANISM_TAXID: 2697049; SOURCE 15 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS SARS-COV-2, ANTIBODY, VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR S.DU,J.Y.XIAO REVDAT 1 28-DEC-22 7WCU 0 JRNL AUTH S.DU,J.Y.XIAO JRNL TITL LOCAL CRYOEM STRUCTURE OF THE SARS-COV-2 S6P(B.1.617.2) IN JRNL TITL 2 COMPLEX WITH SWC11 FAB JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 3.09 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.090 REMARK 3 NUMBER OF PARTICLES : 398316 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7WCU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 21-DEC-21. REMARK 100 THE DEPOSITION ID IS D_1300026483. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : THE SARS-COV-2 S6P(B.1.617.2) REMARK 245 IN COMPLEX WITH SWC11 FAB REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.20 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : DARK FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, R REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 120 REMARK 465 LYS A 121 REMARK 465 GLY A 122 REMARK 465 PRO A 123 REMARK 465 SER A 124 REMARK 465 VAL A 125 REMARK 465 PHE A 126 REMARK 465 PRO A 127 REMARK 465 LEU A 128 REMARK 465 ALA A 129 REMARK 465 PRO A 130 REMARK 465 SER A 131 REMARK 465 SER A 132 REMARK 465 LYS A 133 REMARK 465 SER A 134 REMARK 465 THR A 135 REMARK 465 SER A 136 REMARK 465 GLY A 137 REMARK 465 GLY A 138 REMARK 465 THR A 139 REMARK 465 ALA A 140 REMARK 465 ALA A 141 REMARK 465 LEU A 142 REMARK 465 GLY A 143 REMARK 465 CYS A 144 REMARK 465 LEU A 145 REMARK 465 VAL A 146 REMARK 465 LYS A 147 REMARK 465 ASP A 148 REMARK 465 TYR A 149 REMARK 465 PHE A 150 REMARK 465 PRO A 151 REMARK 465 GLU A 152 REMARK 465 PRO A 153 REMARK 465 VAL A 154 REMARK 465 THR A 155 REMARK 465 VAL A 156 REMARK 465 SER A 157 REMARK 465 TRP A 158 REMARK 465 ASN A 159 REMARK 465 SER A 160 REMARK 465 GLY A 161 REMARK 465 ALA A 162 REMARK 465 LEU A 163 REMARK 465 THR A 164 REMARK 465 SER A 165 REMARK 465 GLY A 166 REMARK 465 VAL A 167 REMARK 465 HIS A 168 REMARK 465 THR A 169 REMARK 465 PHE A 170 REMARK 465 PRO A 171 REMARK 465 ALA A 172 REMARK 465 VAL A 173 REMARK 465 LEU A 174 REMARK 465 GLN A 175 REMARK 465 SER A 176 REMARK 465 SER A 177 REMARK 465 GLY A 178 REMARK 465 LEU A 179 REMARK 465 TYR A 180 REMARK 465 SER A 181 REMARK 465 LEU A 182 REMARK 465 SER A 183 REMARK 465 SER A 184 REMARK 465 VAL A 185 REMARK 465 VAL A 186 REMARK 465 THR A 187 REMARK 465 VAL A 188 REMARK 465 PRO A 189 REMARK 465 SER A 190 REMARK 465 SER A 191 REMARK 465 SER A 192 REMARK 465 LEU A 193 REMARK 465 GLY A 194 REMARK 465 THR A 195 REMARK 465 GLN A 196 REMARK 465 THR A 197 REMARK 465 TYR A 198 REMARK 465 ILE A 199 REMARK 465 CYS A 200 REMARK 465 ASN A 201 REMARK 465 VAL A 202 REMARK 465 ASN A 203 REMARK 465 HIS A 204 REMARK 465 LYS A 205 REMARK 465 PRO A 206 REMARK 465 SER A 207 REMARK 465 ASN A 208 REMARK 465 THR A 209 REMARK 465 LYS A 210 REMARK 465 VAL A 211 REMARK 465 ASP A 212 REMARK 465 LYS A 213 REMARK 465 LYS A 214 REMARK 465 VAL A 215 REMARK 465 GLU A 216 REMARK 465 PRO A 217 REMARK 465 LYS A 218 REMARK 465 SER A 219 REMARK 465 CYS A 220 REMARK 465 ASP A 221 REMARK 465 LYS A 222 REMARK 465 THR R 333 REMARK 465 LEU R 517 REMARK 465 LEU R 518 REMARK 465 HIS R 519 REMARK 465 ALA R 520 REMARK 465 PRO R 521 REMARK 465 PRO R 527 REMARK 465 LYS R 528 REMARK 465 LYS R 529 REMARK 465 SER R 530 REMARK 465 THR R 531 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS R 432 CA - CB - SG ANGL. DEV. = 13.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 26 -7.08 72.03 REMARK 500 VAL A 48 -60.13 -106.96 REMARK 500 SER A 74 -36.30 -132.20 REMARK 500 ASP A 101 43.35 -105.66 REMARK 500 PHE A 102 -66.48 -103.47 REMARK 500 SER A 117 75.90 -101.25 REMARK 500 PRO B 15 83.36 -69.64 REMARK 500 ALA B 30 -70.05 -62.73 REMARK 500 ALA B 51 -3.12 67.24 REMARK 500 ALA B 55 -74.53 -67.01 REMARK 500 LEU B 78 71.36 60.14 REMARK 500 ARG B 108 -167.24 -124.29 REMARK 500 ALA R 352 67.03 -102.44 REMARK 500 THR R 470 35.25 -96.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN A 73 SER A 74 149.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-32429 RELATED DB: EMDB REMARK 900 LOCAL CRYOEM STRUCTURE OF THE SARS-COV-2 S6P(B.1.617.2) IN COMPLEX REMARK 900 WITH SWC11 FAB DBREF 7WCU A 1 222 PDB 7WCU 7WCU 1 222 DBREF 7WCU B 1 109 PDB 7WCU 7WCU 1 109 DBREF1 7WCU R 333 531 UNP A0A8A5S0C0_SARS2 DBREF2 7WCU R A0A8A5S0C0 8 206 SEQADV 7WCU ARG R 452 UNP A0A8A5S0C LEU 127 CONFLICT SEQRES 1 A 222 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU ILE GLN SEQRES 2 A 222 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLU SEQRES 3 A 222 PHE ILE VAL SER ARG ASN TYR MET SER TRP VAL ARG GLN SEQRES 4 A 222 ALA PRO GLY THR GLY LEU GLU TRP VAL SER VAL ILE TYR SEQRES 5 A 222 PRO GLY GLY SER THR PHE TYR ALA ASP SER VAL LYS GLY SEQRES 6 A 222 ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR LEU SEQRES 7 A 222 TYR LEU GLN MET ASP SER LEU ARG VAL GLU ASP THR ALA SEQRES 8 A 222 VAL TYR TYR CYS ALA ARG ASP TYR GLY ASP PHE TYR PHE SEQRES 9 A 222 ASP TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER SER SEQRES 10 A 222 ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA PRO SEQRES 11 A 222 SER SER LYS SER THR SER GLY GLY THR ALA ALA LEU GLY SEQRES 12 A 222 CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR VAL SEQRES 13 A 222 SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS THR SEQRES 14 A 222 PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER LEU SEQRES 15 A 222 SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY THR SEQRES 16 A 222 GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER ASN SEQRES 17 A 222 THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SER CYS ASP SEQRES 18 A 222 LYS SEQRES 1 B 109 GLU ILE VAL MET THR GLN SER PRO VAL SER LEU SER VAL SEQRES 2 B 109 SER PRO GLY GLU ARG ALA THR LEU SER CYS ARG ALA SER SEQRES 3 B 109 GLN GLY VAL ALA SER ASN LEU ALA TRP TYR GLN GLN LYS SEQRES 4 B 109 ALA GLY GLN ALA PRO ARG LEU LEU ILE TYR GLY ALA SER SEQRES 5 B 109 THR ARG ALA THR GLY ILE PRO ALA ARG PHE SER GLY SER SEQRES 6 B 109 GLY SER GLY THR GLU PHE THR LEU THR ILE SER THR LEU SEQRES 7 B 109 GLN SER GLU ASP SER ALA VAL TYR TYR CYS GLN GLN TYR SEQRES 8 B 109 ASN ASP ARG PRO ARG THR PHE GLY GLN GLY THR LYS LEU SEQRES 9 B 109 GLU ILE LYS ARG THR SEQRES 1 R 199 THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA THR SEQRES 2 R 199 ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG ILE SEQRES 3 R 199 SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SER SEQRES 4 R 199 ALA SER PHE SER THR PHE LYS CYS TYR GLY VAL SER PRO SEQRES 5 R 199 THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR ALA SEQRES 6 R 199 ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN ILE SEQRES 7 R 199 ALA PRO GLY GLN THR GLY LYS ILE ALA ASP TYR ASN TYR SEQRES 8 R 199 LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA TRP SEQRES 9 R 199 ASN SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN TYR SEQRES 10 R 199 ASN TYR ARG TYR ARG LEU PHE ARG LYS SER ASN LEU LYS SEQRES 11 R 199 PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN ALA SEQRES 12 R 199 GLY SER LYS PRO CYS ASN GLY VAL GLU GLY PHE ASN CYS SEQRES 13 R 199 TYR PHE PRO LEU GLN SER TYR GLY PHE GLN PRO THR ASN SEQRES 14 R 199 GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SER SEQRES 15 R 199 PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY PRO SEQRES 16 R 199 LYS LYS SER THR HELIX 1 AA1 ILE A 28 ASN A 32 5 5 HELIX 2 AA2 ARG A 86 THR A 90 5 5 HELIX 3 AA3 GLN B 79 SER B 83 5 5 HELIX 4 AA4 PHE R 338 ASN R 343 1 6 HELIX 5 AA5 TYR R 365 ASN R 370 1 6 HELIX 6 AA6 ASP R 405 ILE R 410 5 6 HELIX 7 AA7 LYS R 417 ASN R 422 1 6 HELIX 8 AA8 SER R 438 SER R 443 1 6 HELIX 9 AA9 GLY R 502 TYR R 505 5 4 SHEET 1 AA1 4 GLN A 3 SER A 7 0 SHEET 2 AA1 4 SER A 17 SER A 25 -1 O ALA A 23 N VAL A 5 SHEET 3 AA1 4 LEU A 80 ASP A 83 -1 O MET A 82 N LEU A 18 SHEET 4 AA1 4 PHE A 67 ILE A 69 -1 N THR A 68 O GLN A 81 SHEET 1 AA2 6 LEU A 11 ILE A 12 0 SHEET 2 AA2 6 THR A 111 VAL A 115 1 O THR A 114 N ILE A 12 SHEET 3 AA2 6 ALA A 91 TYR A 99 -1 N TYR A 93 O THR A 111 SHEET 4 AA2 6 TYR A 33 GLN A 39 -1 N VAL A 37 O TYR A 94 SHEET 5 AA2 6 LEU A 45 ILE A 51 -1 O GLU A 46 N ARG A 38 SHEET 6 AA2 6 THR A 57 TYR A 59 -1 O PHE A 58 N VAL A 50 SHEET 1 AA3 4 LEU A 11 ILE A 12 0 SHEET 2 AA3 4 THR A 111 VAL A 115 1 O THR A 114 N ILE A 12 SHEET 3 AA3 4 ALA A 91 TYR A 99 -1 N TYR A 93 O THR A 111 SHEET 4 AA3 4 TYR A 103 TRP A 107 -1 O TYR A 103 N TYR A 99 SHEET 1 AA4 3 THR B 5 GLN B 6 0 SHEET 2 AA4 3 ALA B 19 VAL B 29 -1 O ARG B 24 N THR B 5 SHEET 3 AA4 3 SER B 65 ILE B 75 -1 O LEU B 73 N LEU B 21 SHEET 1 AA5 6 SER B 10 VAL B 13 0 SHEET 2 AA5 6 THR B 102 ILE B 106 1 O GLU B 105 N VAL B 13 SHEET 3 AA5 6 ALA B 84 GLN B 90 -1 N TYR B 86 O THR B 102 SHEET 4 AA5 6 LEU B 33 GLN B 38 -1 N GLN B 38 O VAL B 85 SHEET 5 AA5 6 ARG B 45 TYR B 49 -1 O ARG B 45 N GLN B 37 SHEET 6 AA5 6 THR B 53 ARG B 54 -1 O THR B 53 N TYR B 49 SHEET 1 AA6 5 ASN R 354 ILE R 358 0 SHEET 2 AA6 5 VAL R 395 ARG R 403 -1 O VAL R 395 N ILE R 358 SHEET 3 AA6 5 PRO R 507 PHE R 515 -1 O VAL R 512 N ASP R 398 SHEET 4 AA6 5 GLY R 431 ASN R 437 -1 N CYS R 432 O LEU R 513 SHEET 5 AA6 5 THR R 376 TYR R 380 -1 N THR R 376 O ALA R 435 SHEET 1 AA7 2 ARG R 452 ARG R 454 0 SHEET 2 AA7 2 LEU R 492 SER R 494 -1 O GLN R 493 N TYR R 453 SHEET 1 AA8 2 TYR R 473 GLN R 474 0 SHEET 2 AA8 2 CYS R 488 TYR R 489 -1 O TYR R 489 N TYR R 473 SSBOND 1 CYS A 22 CYS A 95 1555 1555 2.03 SSBOND 2 CYS B 23 CYS B 88 1555 1555 2.04 SSBOND 3 CYS R 336 CYS R 361 1555 1555 2.03 SSBOND 4 CYS R 379 CYS R 432 1555 1555 2.06 SSBOND 5 CYS R 391 CYS R 525 1555 1555 2.04 SSBOND 6 CYS R 480 CYS R 488 1555 1555 2.03 CISPEP 1 ARG B 94 PRO B 95 0 8.79 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000